Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine for Cataract Surgery Sedation
NCT05698758Unknown
- Sponsor
- Guangzhou First People's Hospital
- Start
- Jan 2023
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in cataract comparing Dexmedetomidine Group with Placebo Group (2 arms). Primary endpoint: Overall patients satisfaction with preoperative sedation. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
cataract
Beyond the preview
Go deeper on NCT05698758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05698758.